From lipoproteins to chondrocytes: a brief summary of the European Medicines Agency's regulatory guidelines for advanced therapy medicinal products

Hum Gene Ther. 2013 Jun;24(6):568-70. doi: 10.1089/hum.2013.101.
No abstract available

MeSH terms

  • Chondrocytes / cytology*
  • Drug Industry / legislation & jurisprudence
  • Europe
  • European Union
  • Guidelines as Topic*
  • Humans
  • Legislation, Drug*
  • Lipoproteins / metabolism*

Substances

  • Lipoproteins